Top executives from five pharmaceutical companies including
Lawmakers heading into the 2020 elections face increasing pressure to pare back the costs consumers pay for drugs. On the table are proposals that would empower the federal government to demand lower prices for certain medicines. Another aims to overhaul Medicare to reduce what seniors pay.
The campaign of Senate Majority Leader
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.